| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446192 | European Journal of Cancer | 2012 | 11 Pages |
Abstract
KIT mutations predict treatment outcome with KIT inhibitors. Therefore, especially vulvar melanoma patients should be screened for activating KIT mutations.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nicola L. Schoenewolf, Christian Bull, Benedetta Belloni, David Holzmann, Sabina Tonolla, Roland Lang, Daniela Mihic-Probst, Christian Andres, Reinhard Dummer,